MED12 loss activates endogenous retroelements to sensitise immunotherapy in pancreatic cancer. Tang Y, Tang S, Yang W, Zhang Z, et al. Gut 2024 Aug 31:gutjnl-2024-332350. doi: 10.1136/gutjnl-2024-332350.

Read + Share

Amedeo Smart

Independent Medical Education

Tang Y, Tang S, Yang W, Zhang Z, et al. MED12 loss activates endogenous retroelements to sensitise immunotherapy in pancreatic cancer. Gut 2024 Aug 31:gutjnl-2024-332350. doi: 10.1136/gutjnl-2024-332350.
PMID: 39216984